The acquisition is the latest in a series of strategic acquisitions made by Wolters Kluwer Health in its Clinical Solutions business as part of the company’s focus on serving the point-of-care segment, according to a news release.
“Wolters Kluwer Health has focused heavily on building a robust suite of clinical decision support solutions for point-of-care use by healthcare professionals, and our acquisition of Lexi-Comp is very much aligned with this strategy,” said Arvind Subramanian, president & CEO, Wolters Kluwer Health Clinical Solutions, in the news release. “Like Wolters Kluwer Health’s Clinical Solutions businesses, Lexi-Comp is a leader in providing quality drug information and clinical content designed to help pharmacists and other healthcare professionals make informed and efficient clinical judgments and decisions to improve the quality of care they can provide for their patients. With this acquisition, over 500,000 pharmacists and clinicians in 149 countries will have access to Wolters Kluwer Health Clinical Solutions offerings.”
Lexi-Comp provides drug information and medical reference content to more than 1,500 hospitals internationally, and publishes drug monographs covering more than 1,700 products.
Read the news release about the acquisition of Lexi-Comp by Wolters Kluwer Health.
Read Related Articles on Wolters Kluwer Health:
Nathan Littauer Hospital in New York Selects ProVation Order Sets
Advanced Endoscopy & Surgical Center in New Jersey Selects ProVation MD Software
Williamson Medical Center in Tennessee Selects ProVation Order Sets
